The engineering of an orally active conotoxin for the treatment of neuropathic pain
From killers to curers: Peptides from cone snail venoms are potential therapeutic agents for the treatment of neuropathic pain. Unfortunately, these peptides suffer from the disadvantage of short biological half-lives and poor activity when taken orally. A new orally active conotoxin was developed to solve these problems.
Please refer to publisher version or contact your library.